Sono-Tek Corp (SOTK)
NASDAQInformation TechnologyIndustrial - MachinerySnapshot 2026-09-04
NASDAQInformation TechnologyIndustrial - MachinerySnapshot 2026-09-04
Intact: The reason to own it still holds.
Sono-Tek makes ultrasonic coating systems with steady sales growth. Revenue rose from $5.03M in 2025-Q1 to $5.61M in 2026-Q4. Cash from operations improved from negative $177K to positive $3.14M in the same period. The company is on track to modest revenue growth and better cash flow.
The recent sharp 7.9% one-day stock drop shows market doubts. Profit margins and revenue growth could weaken. Cash flow improvements might stall, hurting financial stability.
The price is about 0% above our $5.21 fair value. Analysts expect roughly 9% revenue growth. Our view aligns with these expectations.
Breaks if: cash from operations falls below zero in any quarter through 2026-Q4
Breaks if: profit margins decline significantly below recent levels in next 4 quarters
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a stable growth opportunity with a focus on the medical sector. The current thesis is intact, supported by management's consistent execution on revenue and profitability goals.
The market appears to have priced in a neutral valuation, reflecting a low expectations gap. SOTK is valued at a premium compared to peers, indicating that some positive performance is already anticipated.
Management is on track to achieve modest revenue growth and expand profitability, as evidenced by recent financial results. However, there is a near-term risk of missing earnings expectations, which could impact sentiment.
The long-term thesis hinges on SOTK's ability to maintain guidance and execute on its growth strategies. Additionally, external factors like Federal Reserve interest rate decisions and performance from sector peers will play a significant role.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The company received a record $3.6 million production line order. This order strongly reinforces its objective to achieve modest revenue growth. There are no new threats impacting the thesis at this time.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Breaks if: revenue falls below $5.03 million in any quarter through 2026-Q4
Breaks if: major management departures or disruptions occur
Overall, SOTK's fundamentals are strong, but caution is warranted due to potential near-term risks. Not investment advice.